Escitalopram and outcomes among patients with depression and heart failure-reply

JAMA - Journal of the American Medical Association

Volumn 316, Issue 14, 2016, Pages 1494-1495

  Angermann, Christiane E ^a   Deckert, Jürgen ^a   Ertl, Georg ^a  

^a UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ESCITALOPRAM; CITALOPRAM; SEROTONIN UPTAKE INHIBITOR;

COMORBIDITY; DEPRESSION; DISEASE DURATION; DISEASE SEVERITY; DRUG EFFICACY; HEART FAILURE; HOSPITALIZATION; HUMAN; LETTER; MORBIDITY; MORTALITY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; TREATMENT RESPONSE; DEPRESSIVE DISORDER; DEPRESSIVE DISORDER, MAJOR; DOUBLE BLIND PROCEDURE; TREATMENT OUTCOME;

CITALOPRAM; DEPRESSION; DEPRESSIVE DISORDER; DEPRESSIVE DISORDER, MAJOR; DOUBLE-BLIND METHOD; HEART FAILURE; HUMANS; SEROTONIN UPTAKE INHIBITORS; TREATMENT OUTCOME;

EID: 84997079549     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2016.13888     Document Type: Letter

References (5)

1. Hare DL, Toukhsati SR, Johansson P, Jaarsma T. Depression and cardiovascular disease: a clinical review. Eur Heart J. 2014;35(21):1365-1372.
2. Piepenburg SM, Faller H, Gelbrich G, et al. Comparative potential of the 2-item versus the 9-item patient health questionnaire to predict death or rehospitalization in heart failure. Circ Heart Fail. 2015;8(3):464-472.
3. Sherwood A, Blumenthal JA, Hinderliter AL, et al.Worsening depressive symptoms are associated with adverse clinical outcomes in patients with heart failure. J AmColl Cardiol. 2011;57(4):418-423.
4. JiangW, Krishnan R, Kuchibhatla M, et al; SADHART-CHF Investigators. Characteristics of depression remission and its relation with cardiovascular outcome among patients with chronic heart failure (from the SADHART-CHF Study). Am J Cardiol. 2011;107(4):545-551.
5. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. (DSM-IV).Washington, DC: American Psychiatric Association, 1994.